Why BioMarin FDA Panel is Positive for Sarepta (SRPT) - Oppenheimer
Go back to Why BioMarin FDA Panel is Positive for Sarepta (SRPT) - Oppenheimer| BioMarin Pharmaceuticals, Inc. (NASDAQ: BMRN) | Delayed: 63.37 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $63.37 | 52 Week High | $108.96 | |||
| Open | $63.37 | 52 Week Low | $62.12 | |||
| Day High | $63.37 | P/E | N/A | |||
| Day Low | $63.37 | EPS | $-1.27 | |||
| Volume | 3,233 | |||||
| SAREPTA THERAP (NASDAQ: SRPT) | Delayed: 20.81 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $20.81 | 52 Week High | $63.73 | |||
| Open | $20.81 | 52 Week Low | $8.00 | |||
| Day High | $20.81 | P/E | N/A | |||
| Day Low | $20.81 | EPS | $-5.69 | |||
| Volume | 358 | |||||
